BPC-157 could assist in mucosal healing, strengthen tight junctions to prevent leaky gut, and protect against tissue damage caused by chronic inflammation, supporting ulcer repair and symptom relief in Crohns disease
For example, a patient stepping down from 2 mg of semaglutide weekly might see 0.25 mg as a microdose, even though it is the standard approved starting dose
However, in general, the longer you take these drugs, the more likely you are to receive a diagnosis related to mental health
Among patients with T2D who had no prior history of CUD, semaglutide was associated with a significantly lower risk for incident CUD diagnosis compared with non-GLP-1RA anti-diabetes medications for a 12-month follow-up period (0.21% vs
Gastroenterology 73 , 215217 (1977)
Conclusion Administering GLP-1 medications can be a straightforward and effective way to manage type 2 diabetes and obesity